Prevalence of gestational diabetes mellitus based on various screening strategies in western Kenya: a prospective comparison of point of care diagnostic methods
- PMID: 28705184
- PMCID: PMC5513206
- DOI: 10.1186/s12884-017-1415-4
Prevalence of gestational diabetes mellitus based on various screening strategies in western Kenya: a prospective comparison of point of care diagnostic methods
Abstract
Background: Early diagnosis of gestational diabetes mellitus (GDM) is crucial to prevent short term delivery risks and long term effects such as cardiovascular and metabolic diseases in the mother and infant. Diagnosing GDM in Sub-Saharan Africa (SSA) however, remains sub-optimal due to associated logistical and cost barriers for resource-constrained populations. A cost-effective strategy to screen for GDM in such settings are therefore urgently required. We conducted this study to determine the prevalence of gestational diabetes mellitus (GDM) and assess utility of various GDM point of care (POC) screening strategies in a resource-constrained setting.
Methods: Eligible women aged ≥18 years, and between 24 and 32 weeks of a singleton pregnancy, prospectively underwent testing over two days. On day 1, a POC 1-h 50 g glucose challenge test (GCT) and a POC glycated hemoglobin (HbA1c) was assessed. On day 2, fasting blood glucose, 1-h and 2-h 75 g oral glucose tolerance test (OGTT) were determined using both venous and POC tests, along with a venous HbA1c. The International Association of Diabetes in Pregnancy Study Group (IADPSG) criteria was used to diagnose GDM. GDM prevalence was reported with 95% confidence interval (CI). Specificity, sensitivity, positive predictive value, and negative predictive value of the various POC testing strategies were determined using IADPSG testing as the standard reference.
Results: Six hundred-sixteen eligible women completed testing procedures. GDM was diagnosed in 18 women, a prevalence of 2.9% (95% CI, 1.57% - 4.23%). Compared to IADPSG testing, POC IADPSG had a sensitivity and specificity of 55.6% and 90.6% respectively while that of POC 1-h 50 g GCT (using a diagnostic cut-off of ≥7.2 mmol/L [129.6 mg/dL]) was 55.6% and 63.9%. All other POC tests assessed showed poor sensitivity.
Conclusions: POC screening strategies though feasible, showed poor sensitivity for GDM detection in our resource-constrained population of low GDM prevalence. Studies to identify sensitive and specific POC GDM screening strategies using adverse pregnancy outcomes as end points are required.
Trials registration: Clinical trials.gov : NCT02978807 , Registered 29 November 2016.
Keywords: Diagnosis; Gestational diabetes mellitus; Low middle income; Prevalence; Screening.
Conflict of interest statement
Ethics approval and consent to participate
Full approval from the Moi University and Moi Teaching and Referral Hospital institutional research ethics committee and the Indiana University-Purdue University institutional review board were acquired prior to study initiation. Written informed consent was obtained from all participants.
Consent for publication
Not Applicable.
Competing interests
Donations of insulin were received from Eli Lilly and Company and donated point of care glucose testing supplies were received from Abbott Diabetes Care.
Sonak Pastakia has previously served as a consultant for Abbott Diabetes Care but the work presented here is unrelated to those efforts. The other authors have no conflict of interest to declare
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures


Similar articles
-
The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes.Am J Obstet Gynecol. 2015 Feb;212(2):224.e1-9. doi: 10.1016/j.ajog.2014.08.027. Epub 2014 Aug 27. Am J Obstet Gynecol. 2015. PMID: 25173183
-
Evaluation of point-of-care maternal glucose measurements for the diagnosis of gestational diabetes mellitus.BJOG. 2017 Oct;124(11):1746-1752. doi: 10.1111/1471-0528.14255. Epub 2016 Aug 17. BJOG. 2017. PMID: 27532888
-
Characteristics of different risk factors and fasting plasma glucose for identifying GDM when using IADPSG criteria: a cross-sectional study.BMC Pregnancy Childbirth. 2018 Jun 13;18(1):225. doi: 10.1186/s12884-018-1875-1. BMC Pregnancy Childbirth. 2018. PMID: 29898685 Free PMC article.
-
Screening and diagnosing gestational diabetes mellitus.Evid Rep Technol Assess (Full Rep). 2012 Oct;(210):1-327. Evid Rep Technol Assess (Full Rep). 2012. PMID: 24423035 Free PMC article. Review.
-
The 2019 Flemish consensus on screening for overt diabetes in early pregnancy and screening for gestational diabetes mellitus.Acta Clin Belg. 2020 Oct;75(5):340-347. doi: 10.1080/17843286.2019.1637389. Epub 2019 Jul 1. Acta Clin Belg. 2020. PMID: 31259665
Cited by
-
The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus.PLoS One. 2021 Sep 13;16(9):e0257391. doi: 10.1371/journal.pone.0257391. eCollection 2021. PLoS One. 2021. PMID: 34516586 Free PMC article.
-
COVID-19 pandemic: Can fasting plasma glucose and HbA1c replace the oral glucose tolerance test to screen for hyperglycaemia in pregnancy?Diabetes Res Clin Pract. 2021 Feb;172:108640. doi: 10.1016/j.diabres.2020.108640. Epub 2021 Jan 13. Diabetes Res Clin Pract. 2021. PMID: 33359083 Free PMC article.
-
Limiting the Use of Oral Glucose Tolerance Tests to Screen for Hyperglycemia in Pregnancy during Pandemics.J Clin Med. 2021 Jan 21;10(3):397. doi: 10.3390/jcm10030397. J Clin Med. 2021. PMID: 33494289 Free PMC article.
-
Rising prevalence of gestational diabetes mellitus and its associated risk factors in Makurdi, North-Central Region of Nigeria.Afr Health Sci. 2023 Dec;23(4):348-355. doi: 10.4314/ahs.v23i4.37. Afr Health Sci. 2023. PMID: 38974298 Free PMC article.
-
Prevalence of gestational diabetes mellitus among women attending antenatal care at public health centers in Rwanda.Diabetes Res Clin Pract. 2019 May;151:252-259. doi: 10.1016/j.diabres.2019.03.035. Epub 2019 Apr 1. Diabetes Res Clin Pract. 2019. PMID: 30946850 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials